2024年10月30日,医疗器械龙头企业齐默巴奥米特控股(ZBH.US)股价在盘中出现大涨,一度上涨5.22%,引发市场广泛关注。
分析人士认为,公司当日股价大涨主要由于公司当日公布的下调2024年财年指引低于市场预期,但实际数据却好于外界预期。具体来看,齐默巴奥米特控股预计2024年每股收益在7.95至8.05美元之间,低于之前预测的8.00-8.15美元区间;同时公司下调年营收增长指引,由之前的4%-5%调至3.5%-4%。
尽管公司下调了财年指引,但实际数字依然超出了市场预期。多家分析机构认为,影响并不太大。贝尔德(Baird)指出,下调每股收益预期的影响没有人们担心的那么大;RBC资本市场表示,修订后的2024年展望略好于预期,因为其基本销售额符合最近下调的共识,而每股收益则高于预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.